Li Z - Search Results

1

The molecular basis for the selectivity of tadalafil toward phosphodiesterase 5 and 6: a modeling study.

Huang YY, Li Z, Cai YH, Feng LJ, Wu Y, Li X, Luo HB. Huang YY, et al. Among authors: li z, li x. J Chem Inf Model. 2013 Nov 25;53(11):3044-53. doi: 10.1021/ci400458z. Epub 2013 Nov 12. J Chem Inf Model. 2013. PMID: 24180640

2

Structural investigation into the inhibitory mechanisms of indomethacin and its analogues towards human glyoxalase I.

Liu M, Yuan M, Li Z, Cheng YK, Luo HB, Hu X. Liu M, et al. Among authors: li z. Bioorg Med Chem Lett. 2011 Jul 15;21(14):4243-7. doi: 10.1016/j.bmcl.2011.05.095. Epub 2011 Jun 1. Bioorg Med Chem Lett. 2011. PMID: 21689932

3

The molecular basis for the inhibition of human cytochrome P450 1A2 by oroxylin and wogonin.

Shao YX, Zhao P, Li Z, Liu M, Liu P, Huang M, Luo HB. Shao YX, et al. Among authors: li z. Eur Biophys J. 2012 Mar;41(3):297-306. doi: 10.1007/s00249-011-0785-1. Epub 2012 Jan 8. Eur Biophys J. 2012. PMID: 22228220

4

Quantitative structure-retention relationship of curcumin and its analogues.

Zheng XH, Shao YX, Li Z, Liu M, Bu X, Luo HB, Hu X. Zheng XH, et al. Among authors: li z. J Sep Sci. 2012 Feb;35(4):505-12. doi: 10.1002/jssc.201100903. J Sep Sci. 2012. PMID: 22282411

5

Moracin M from Morus alba L. is a natural phosphodiesterase-4 inhibitor.

Chen SK, Zhao P, Shao YX, Li Z, Zhang C, Liu P, He X, Luo HB, Hu X. Chen SK, et al. Among authors: li z. Bioorg Med Chem Lett. 2012 May 1;22(9):3261-4. doi: 10.1016/j.bmcl.2012.03.026. Epub 2012 Mar 21. Bioorg Med Chem Lett. 2012. PMID: 22483586

6

Structure-based discovery of highly selective phosphodiesterase-9A inhibitors and implications for inhibitor design.

Meng F, Hou J, Shao YX, Wu PY, Huang M, Zhu X, Cai Y, Li Z, Xu J, Liu P, Luo HB, Wan Y, Ke H. Meng F, et al. Among authors: li z. J Med Chem. 2012 Oct 11;55(19):8549-58. doi: 10.1021/jm301189c. Epub 2012 Oct 1. J Med Chem. 2012. PMID: 22985069 Free PMC article.

7

Identification of novel phosphodiesterase-4D inhibitors prescreened by molecular dynamics-augmented modeling and validated by bioassay.

Li Z, Cai YH, Cheng YK, Lu X, Shao YX, Li X, Liu M, Liu P, Luo HB. Li Z, et al. Among authors: li x. J Chem Inf Model. 2013 Apr 22;53(4):972-81. doi: 10.1021/ci400063s. Epub 2013 Mar 29. J Chem Inf Model. 2013. PMID: 23517293

8

The molecular basis for the inhibition of phosphodiesterase-4D by three natural resveratrol analogs. Isolation, molecular docking, molecular dynamics simulations, binding free energy, and bioassay.

Zhao P, Chen SK, Cai YH, Lu X, Li Z, Cheng YK, Zhang C, Hu X, He X, Luo HB. Zhao P, et al. Among authors: li z. Biochim Biophys Acta. 2013 Oct;1834(10):2089-96. doi: 10.1016/j.bbapap.2013.07.004. Epub 2013 Jul 19. Biochim Biophys Acta. 2013. PMID: 23871879

9

Discovery of 3-(4-hydroxybenzyl)-1-(thiophen-2-yl)chromeno[2,3-c]pyrrol-9(2H)-one as a phosphodiesterase-5 inhibitor and its complex crystal structure.

Shang NN, Shao YX, Cai YH, Guan M, Huang M, Cui W, He L, Yu YJ, Huang L, Li Z, Bu XZ, Ke H, Luo HB. Shang NN, et al. Among authors: li z. Biochem Pharmacol. 2014 May 1;89(1):86-98. doi: 10.1016/j.bcp.2014.02.013. Epub 2014 Feb 22. Biochem Pharmacol. 2014. PMID: 24565909

10

AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy.

Liu M, Li Z, Chen GW, Li ZM, Wang LP, Ye JT, Luo HB, Liu PQ. Liu M, et al. Among authors: li zm, li z. Mol Cell Endocrinol. 2014 Jul 5;392(1-2):14-22. doi: 10.1016/j.mce.2014.05.010. Epub 2014 May 21. Mol Cell Endocrinol. 2014. PMID: 24859603

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113,180 results

Search Page

Filters